UPDATE
3-Bowing to
pressure, U.S. FDA
approves Sarepta?s Duchenne drug
Sept 19 (Reuters) - Bowing to pressure from patientadvocates, the
U.S. Food and
drug Administration on Mondayapproved a treatment for
Duchenne muscular dystrophy even thoughan outside panel of...